The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Microbiome Modulator Market Research Report 2024
Synopsis
The global Microbiome Modulator market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Microbiome Modulator is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Microbiome Modulator is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Microbiome Modulator in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Microbiome Modulator include Sanofi, DSM, DuPont, BioGaia, Chr. Hansen, Ingredion, Immuron, MICROBIOME THERAPEUTICS, Quorum Innovations, Merck Sharp & Dohme, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Microbiome Modulator, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Microbiome Modulator.
The Microbiome Modulator market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Microbiome Modulator market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Microbiome Modulator companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
DSM
DuPont
BioGaia
Chr. Hansen
Ingredion
Immuron
MICROBIOME THERAPEUTICS
Quorum Innovations
Merck Sharp & Dohme
Symbiotix Biotherapies
Ritter Pharmaceuticals
Segment by Type
Prebiotics
Probiotics
Drugs
Other
Segment by Application
Hospital
Specialty Clinic
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Microbiome Modulator company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Microbiome Modulator market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Microbiome Modulator is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Microbiome Modulator is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Microbiome Modulator in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Microbiome Modulator include Sanofi, DSM, DuPont, BioGaia, Chr. Hansen, Ingredion, Immuron, MICROBIOME THERAPEUTICS, Quorum Innovations, Merck Sharp & Dohme, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Microbiome Modulator, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Microbiome Modulator.
The Microbiome Modulator market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Microbiome Modulator market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Microbiome Modulator companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
DSM
DuPont
BioGaia
Chr. Hansen
Ingredion
Immuron
MICROBIOME THERAPEUTICS
Quorum Innovations
Merck Sharp & Dohme
Symbiotix Biotherapies
Ritter Pharmaceuticals
Segment by Type
Prebiotics
Probiotics
Drugs
Other
Segment by Application
Hospital
Specialty Clinic
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Microbiome Modulator company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Microbiome Modulator Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Prebiotics
1.2.3 Probiotics
1.2.4 Drugs
1.2.5 Other
1.3 Market by Application
1.3.1 Global Microbiome Modulator Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Specialty Clinic
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Microbiome Modulator Market Perspective (2019-2030)
2.2 Global Microbiome Modulator Growth Trends by Region
2.2.1 Global Microbiome Modulator Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Microbiome Modulator Historic Market Size by Region (2019-2024)
2.2.3 Microbiome Modulator Forecasted Market Size by Region (2025-2030)
2.3 Microbiome Modulator Market Dynamics
2.3.1 Microbiome Modulator Industry Trends
2.3.2 Microbiome Modulator Market Drivers
2.3.3 Microbiome Modulator Market Challenges
2.3.4 Microbiome Modulator Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Microbiome Modulator Players by Revenue
3.1.1 Global Top Microbiome Modulator Players by Revenue (2019-2024)
3.1.2 Global Microbiome Modulator Revenue Market Share by Players (2019-2024)
3.2 Global Microbiome Modulator Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Microbiome Modulator Revenue
3.4 Global Microbiome Modulator Market Concentration Ratio
3.4.1 Global Microbiome Modulator Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Microbiome Modulator Revenue in 2023
3.5 Global Key Players of Microbiome Modulator Head office and Area Served
3.6 Global Key Players of Microbiome Modulator, Product and Application
3.7 Global Key Players of Microbiome Modulator, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Microbiome Modulator Breakdown Data by Type
4.1 Global Microbiome Modulator Historic Market Size by Type (2019-2024)
4.2 Global Microbiome Modulator Forecasted Market Size by Type (2025-2030)
5 Microbiome Modulator Breakdown Data by Application
5.1 Global Microbiome Modulator Historic Market Size by Application (2019-2024)
5.2 Global Microbiome Modulator Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Microbiome Modulator Market Size (2019-2030)
6.2 North America Microbiome Modulator Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Microbiome Modulator Market Size by Country (2019-2024)
6.4 North America Microbiome Modulator Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Microbiome Modulator Market Size (2019-2030)
7.2 Europe Microbiome Modulator Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Microbiome Modulator Market Size by Country (2019-2024)
7.4 Europe Microbiome Modulator Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Microbiome Modulator Market Size (2019-2030)
8.2 Asia-Pacific Microbiome Modulator Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Microbiome Modulator Market Size by Region (2019-2024)
8.4 Asia-Pacific Microbiome Modulator Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Microbiome Modulator Market Size (2019-2030)
9.2 Latin America Microbiome Modulator Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Microbiome Modulator Market Size by Country (2019-2024)
9.4 Latin America Microbiome Modulator Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Microbiome Modulator Market Size (2019-2030)
10.2 Middle East & Africa Microbiome Modulator Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Microbiome Modulator Market Size by Country (2019-2024)
10.4 Middle East & Africa Microbiome Modulator Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Details
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Microbiome Modulator Introduction
11.1.4 Sanofi Revenue in Microbiome Modulator Business (2019-2024)
11.1.5 Sanofi Recent Development
11.2 DSM
11.2.1 DSM Company Details
11.2.2 DSM Business Overview
11.2.3 DSM Microbiome Modulator Introduction
11.2.4 DSM Revenue in Microbiome Modulator Business (2019-2024)
11.2.5 DSM Recent Development
11.3 DuPont
11.3.1 DuPont Company Details
11.3.2 DuPont Business Overview
11.3.3 DuPont Microbiome Modulator Introduction
11.3.4 DuPont Revenue in Microbiome Modulator Business (2019-2024)
11.3.5 DuPont Recent Development
11.4 BioGaia
11.4.1 BioGaia Company Details
11.4.2 BioGaia Business Overview
11.4.3 BioGaia Microbiome Modulator Introduction
11.4.4 BioGaia Revenue in Microbiome Modulator Business (2019-2024)
11.4.5 BioGaia Recent Development
11.5 Chr. Hansen
11.5.1 Chr. Hansen Company Details
11.5.2 Chr. Hansen Business Overview
11.5.3 Chr. Hansen Microbiome Modulator Introduction
11.5.4 Chr. Hansen Revenue in Microbiome Modulator Business (2019-2024)
11.5.5 Chr. Hansen Recent Development
11.6 Ingredion
11.6.1 Ingredion Company Details
11.6.2 Ingredion Business Overview
11.6.3 Ingredion Microbiome Modulator Introduction
11.6.4 Ingredion Revenue in Microbiome Modulator Business (2019-2024)
11.6.5 Ingredion Recent Development
11.7 Immuron
11.7.1 Immuron Company Details
11.7.2 Immuron Business Overview
11.7.3 Immuron Microbiome Modulator Introduction
11.7.4 Immuron Revenue in Microbiome Modulator Business (2019-2024)
11.7.5 Immuron Recent Development
11.8 MICROBIOME THERAPEUTICS
11.8.1 MICROBIOME THERAPEUTICS Company Details
11.8.2 MICROBIOME THERAPEUTICS Business Overview
11.8.3 MICROBIOME THERAPEUTICS Microbiome Modulator Introduction
11.8.4 MICROBIOME THERAPEUTICS Revenue in Microbiome Modulator Business (2019-2024)
11.8.5 MICROBIOME THERAPEUTICS Recent Development
11.9 Quorum Innovations
11.9.1 Quorum Innovations Company Details
11.9.2 Quorum Innovations Business Overview
11.9.3 Quorum Innovations Microbiome Modulator Introduction
11.9.4 Quorum Innovations Revenue in Microbiome Modulator Business (2019-2024)
11.9.5 Quorum Innovations Recent Development
11.10 Merck Sharp & Dohme
11.10.1 Merck Sharp & Dohme Company Details
11.10.2 Merck Sharp & Dohme Business Overview
11.10.3 Merck Sharp & Dohme Microbiome Modulator Introduction
11.10.4 Merck Sharp & Dohme Revenue in Microbiome Modulator Business (2019-2024)
11.10.5 Merck Sharp & Dohme Recent Development
11.11 Symbiotix Biotherapies
11.11.1 Symbiotix Biotherapies Company Details
11.11.2 Symbiotix Biotherapies Business Overview
11.11.3 Symbiotix Biotherapies Microbiome Modulator Introduction
11.11.4 Symbiotix Biotherapies Revenue in Microbiome Modulator Business (2019-2024)
11.11.5 Symbiotix Biotherapies Recent Development
11.12 Ritter Pharmaceuticals
11.12.1 Ritter Pharmaceuticals Company Details
11.12.2 Ritter Pharmaceuticals Business Overview
11.12.3 Ritter Pharmaceuticals Microbiome Modulator Introduction
11.12.4 Ritter Pharmaceuticals Revenue in Microbiome Modulator Business (2019-2024)
11.12.5 Ritter Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of TablesList of Tables
Table 1. Global Microbiome Modulator Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Prebiotics
Table 3. Key Players of Probiotics
Table 4. Key Players of Drugs
Table 5. Key Players of Other
Table 6. Global Microbiome Modulator Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Microbiome Modulator Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Microbiome Modulator Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Microbiome Modulator Market Share by Region (2019-2024)
Table 10. Global Microbiome Modulator Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Microbiome Modulator Market Share by Region (2025-2030)
Table 12. Microbiome Modulator Market Trends
Table 13. Microbiome Modulator Market Drivers
Table 14. Microbiome Modulator Market Challenges
Table 15. Microbiome Modulator Market Restraints
Table 16. Global Microbiome Modulator Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Microbiome Modulator Market Share by Players (2019-2024)
Table 18. Global Top Microbiome Modulator Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Microbiome Modulator as of 2023)
Table 19. Ranking of Global Top Microbiome Modulator Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Microbiome Modulator Revenue (CR5 and HHI) & (2019-2024)
Table 21. Global Key Players of Microbiome Modulator, Headquarters and Area Served
Table 22. Global Key Players of Microbiome Modulator, Product and Application
Table 23. Global Key Players of Microbiome Modulator, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Microbiome Modulator Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Microbiome Modulator Revenue Market Share by Type (2019-2024)
Table 27. Global Microbiome Modulator Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Microbiome Modulator Revenue Market Share by Type (2025-2030)
Table 29. Global Microbiome Modulator Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Microbiome Modulator Revenue Market Share by Application (2019-2024)
Table 31. Global Microbiome Modulator Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Microbiome Modulator Revenue Market Share by Application (2025-2030)
Table 33. North America Microbiome Modulator Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Microbiome Modulator Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Microbiome Modulator Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Microbiome Modulator Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Microbiome Modulator Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Microbiome Modulator Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Microbiome Modulator Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Microbiome Modulator Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Microbiome Modulator Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Microbiome Modulator Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Microbiome Modulator Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Microbiome Modulator Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Microbiome Modulator Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Microbiome Modulator Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Microbiome Modulator Market Size by Country (2025-2030) & (US$ Million)
Table 48. Sanofi Company Details
Table 49. Sanofi Business Overview
Table 50. Sanofi Microbiome Modulator Product
Table 51. Sanofi Revenue in Microbiome Modulator Business (2019-2024) & (US$ Million)
Table 52. Sanofi Recent Development
Table 53. DSM Company Details
Table 54. DSM Business Overview
Table 55. DSM Microbiome Modulator Product
Table 56. DSM Revenue in Microbiome Modulator Business (2019-2024) & (US$ Million)
Table 57. DSM Recent Development
Table 58. DuPont Company Details
Table 59. DuPont Business Overview
Table 60. DuPont Microbiome Modulator Product
Table 61. DuPont Revenue in Microbiome Modulator Business (2019-2024) & (US$ Million)
Table 62. DuPont Recent Development
Table 63. BioGaia Company Details
Table 64. BioGaia Business Overview
Table 65. BioGaia Microbiome Modulator Product
Table 66. BioGaia Revenue in Microbiome Modulator Business (2019-2024) & (US$ Million)
Table 67. BioGaia Recent Development
Table 68. Chr. Hansen Company Details
Table 69. Chr. Hansen Business Overview
Table 70. Chr. Hansen Microbiome Modulator Product
Table 71. Chr. Hansen Revenue in Microbiome Modulator Business (2019-2024) & (US$ Million)
Table 72. Chr. Hansen Recent Development
Table 73. Ingredion Company Details
Table 74. Ingredion Business Overview
Table 75. Ingredion Microbiome Modulator Product
Table 76. Ingredion Revenue in Microbiome Modulator Business (2019-2024) & (US$ Million)
Table 77. Ingredion Recent Development
Table 78. Immuron Company Details
Table 79. Immuron Business Overview
Table 80. Immuron Microbiome Modulator Product
Table 81. Immuron Revenue in Microbiome Modulator Business (2019-2024) & (US$ Million)
Table 82. Immuron Recent Development
Table 83. MICROBIOME THERAPEUTICS Company Details
Table 84. MICROBIOME THERAPEUTICS Business Overview
Table 85. MICROBIOME THERAPEUTICS Microbiome Modulator Product
Table 86. MICROBIOME THERAPEUTICS Revenue in Microbiome Modulator Business (2019-2024) & (US$ Million)
Table 87. MICROBIOME THERAPEUTICS Recent Development
Table 88. Quorum Innovations Company Details
Table 89. Quorum Innovations Business Overview
Table 90. Quorum Innovations Microbiome Modulator Product
Table 91. Quorum Innovations Revenue in Microbiome Modulator Business (2019-2024) & (US$ Million)
Table 92. Quorum Innovations Recent Development
Table 93. Merck Sharp & Dohme Company Details
Table 94. Merck Sharp & Dohme Business Overview
Table 95. Merck Sharp & Dohme Microbiome Modulator Product
Table 96. Merck Sharp & Dohme Revenue in Microbiome Modulator Business (2019-2024) & (US$ Million)
Table 97. Merck Sharp & Dohme Recent Development
Table 98. Symbiotix Biotherapies Company Details
Table 99. Symbiotix Biotherapies Business Overview
Table 100. Symbiotix Biotherapies Microbiome Modulator Product
Table 101. Symbiotix Biotherapies Revenue in Microbiome Modulator Business (2019-2024) & (US$ Million)
Table 102. Symbiotix Biotherapies Recent Development
Table 103. Ritter Pharmaceuticals Company Details
Table 104. Ritter Pharmaceuticals Business Overview
Table 105. Ritter Pharmaceuticals Microbiome Modulator Product
Table 106. Ritter Pharmaceuticals Revenue in Microbiome Modulator Business (2019-2024) & (US$ Million)
Table 107. Ritter Pharmaceuticals Recent Development
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
Table 111. Authors List of This Report
List of Figures
Figure 1. Microbiome Modulator Picture
Figure 2. Global Microbiome Modulator Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Microbiome Modulator Market Share by Type: 2023 VS 2030
Figure 4. Prebiotics Features
Figure 5. Probiotics Features
Figure 6. Drugs Features
Figure 7. Other Features
Figure 8. Global Microbiome Modulator Market Size by Application (2024-2030) & (US$ Million)
Figure 9. Global Microbiome Modulator Market Share by Application: 2023 VS 2030
Figure 10. Hospital Case Studies
Figure 11. Specialty Clinic Case Studies
Figure 12. Other Case Studies
Figure 13. Microbiome Modulator Report Years Considered
Figure 14. Global Microbiome Modulator Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Microbiome Modulator Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Microbiome Modulator Market Share by Region: 2023 VS 2030
Figure 17. Global Microbiome Modulator Market Share by Players in 2023
Figure 18. Global Top Microbiome Modulator Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Microbiome Modulator as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Microbiome Modulator Revenue in 2023
Figure 20. North America Microbiome Modulator Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Microbiome Modulator Market Share by Country (2019-2030)
Figure 22. United States Microbiome Modulator Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Microbiome Modulator Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Microbiome Modulator Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Microbiome Modulator Market Share by Country (2019-2030)
Figure 26. Germany Microbiome Modulator Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Microbiome Modulator Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Microbiome Modulator Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Microbiome Modulator Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Microbiome Modulator Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Microbiome Modulator Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Microbiome Modulator Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Microbiome Modulator Market Share by Region (2019-2030)
Figure 34. China Microbiome Modulator Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Microbiome Modulator Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Microbiome Modulator Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Microbiome Modulator Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Microbiome Modulator Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Microbiome Modulator Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Microbiome Modulator Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Microbiome Modulator Market Share by Country (2019-2030)
Figure 42. Mexico Microbiome Modulator Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Microbiome Modulator Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Microbiome Modulator Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Microbiome Modulator Market Share by Country (2019-2030)
Figure 46. Turkey Microbiome Modulator Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Microbiome Modulator Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. UAE Microbiome Modulator Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Sanofi Revenue Growth Rate in Microbiome Modulator Business (2019-2024)
Figure 50. DSM Revenue Growth Rate in Microbiome Modulator Business (2019-2024)
Figure 51. DuPont Revenue Growth Rate in Microbiome Modulator Business (2019-2024)
Figure 52. BioGaia Revenue Growth Rate in Microbiome Modulator Business (2019-2024)
Figure 53. Chr. Hansen Revenue Growth Rate in Microbiome Modulator Business (2019-2024)
Figure 54. Ingredion Revenue Growth Rate in Microbiome Modulator Business (2019-2024)
Figure 55. Immuron Revenue Growth Rate in Microbiome Modulator Business (2019-2024)
Figure 56. MICROBIOME THERAPEUTICS Revenue Growth Rate in Microbiome Modulator Business (2019-2024)
Figure 57. Quorum Innovations Revenue Growth Rate in Microbiome Modulator Business (2019-2024)
Figure 58. Merck Sharp & Dohme Revenue Growth Rate in Microbiome Modulator Business (2019-2024)
Figure 59. Symbiotix Biotherapies Revenue Growth Rate in Microbiome Modulator Business (2019-2024)
Figure 60. Ritter Pharmaceuticals Revenue Growth Rate in Microbiome Modulator Business (2019-2024)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
